1. Home
  2. DFTX vs RITM Comparison

DFTX vs RITM Comparison

Compare DFTX & RITM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Definium Therapeutics Inc. Common Shares

DFTX

Definium Therapeutics Inc. Common Shares

SELL

Current Price

$30.21

Market Cap

5.9B

Sector

N/A

ML Signal

SELL

Logo Rithm Capital Corp.

RITM

Rithm Capital Corp.

SELL

Current Price

$8.85

Market Cap

5.3B

Sector

Real Estate

ML Signal

SELL

Company Overview

Basic Information
Metric
DFTX
RITM
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
5.3B
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
DFTX
RITM
Price
$30.21
$8.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
10
Target Price
★ $72.83
$12.80
AVG Volume (30 Days)
1.5M
★ 6.3M
Earning Date
11-09-2026
10-23-2026
Dividend Yield
N/A
★ 11.31%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.54
Revenue
N/A
★ $4,590,228,000.00
Revenue This Year
N/A
$63.34
Revenue Next Year
N/A
$4.17
P/E Ratio
★ N/A
$16.37
Revenue Growth
★ N/A
N/A
52 Week Low
$14.62
$8.31
52 Week High
$49.70
$12.15

Technical Indicators

Market Signals
Indicator
DFTX
RITM
Relative Strength Index (RSI) 37.55 42.21
Support Level $20.43 $8.37
Resistance Level $38.59 $9.56
Average True Range (ATR) 2.10 0.24
MACD -0.21 -0.04
Stochastic Oscillator 3.34 2.39

Price Performance

Historical Comparison
DFTX
RITM

About DFTX Definium Therapeutics Inc. Common Shares

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

About RITM Rithm Capital Corp.

Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights), loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.

Share on Social Networks: